These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7939273)

  • 1. [Bone marrow grafts from unrelated donors].
    Esperou-Bourdeau H
    Rev Prat; 1994 Sep; 44(14):1851-4. PubMed ID: 7939273
    [No Abstract]   [Full Text] [Related]  

  • 2. Allogeneic bone marrow transplantation using unrelated marrow donors.
    Fay JW; Collins RH; Piñeiro L
    Bone Marrow Transplant; 1993; 11 Suppl 1():81-2. PubMed ID: 8448557
    [No Abstract]   [Full Text] [Related]  

  • 3. Mother as HLA haploidentical marrow donor for children with advanced leukemia.
    Polchi P; Galimberti M; Lucarelli G; Durazzi SM; Angelucci E; Baronciani D; Donati M
    Bone Marrow Transplant; 1991; 7 Suppl 2():124. PubMed ID: 1878671
    [No Abstract]   [Full Text] [Related]  

  • 4. BMT from unrelated (UD) or family donors other than HLA identical siblings (FDNS), GVHD prophylaxis, incidence and treatment.
    Ladenstein R; Peters C; Matthes-Martin S; Rosenmayr A; Höcker P; Pötter R; Pötschinger U; Gadner H
    Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():86-91. PubMed ID: 8932806
    [No Abstract]   [Full Text] [Related]  

  • 5. Bone marrow transplantation from unrelated donors for genetic diseases following conditioning with Busulphan and Cyclophosphamide.
    Vellodi A; Jurges E; el-Tumi M; Abdul-Ahad A; Hobbs JR
    Bone Marrow Transplant; 1991; 7 Suppl 2():70. PubMed ID: 1878726
    [No Abstract]   [Full Text] [Related]  

  • 6. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow transplantation from unrelated donors in chronic myelogenous leukemia.
    Ehninger G; Klingebiel T; Schuler U; Einsele H; Schmidt H; Weiss B; Müller CA; Goldmann SF; Grosse-Wilde H; Niethammer D
    Semin Hematol; 1993 Jul; 30(3 Suppl 3):49-50. PubMed ID: 8235708
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone marrow transplantation for leukaemia in Europe. Report from The Working Party Leukaemia.
    Bone Marrow Transplant; 1991; 7 Suppl 2():160-1. PubMed ID: 1878693
    [No Abstract]   [Full Text] [Related]  

  • 9. Bone marrow transplantation for chronic myelogenous leukemia using unrelated donors: the experience at Huddinge Hospital.
    Aschan J; Ringdén O; Ljungman P; Hägglund H; Klaesson S; Dalianis T; Remberger M
    Transplant Proc; 1995 Dec; 27(6):3531-2. PubMed ID: 8540086
    [No Abstract]   [Full Text] [Related]  

  • 10. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
    Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G
    Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
    Farag SS; Bacigalupo A; Eapen M; Hurley C; Dupont B; Caligiuri MA; Boudreau C; Nelson G; Oudshoorn M; van Rood J; Velardi A; Maiers M; Setterholm M; Confer D; Posch PE; Anasetti C; Kamani N; Miller JS; Weisdorf D; Davies SM;
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):876-84. PubMed ID: 16864058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma delta T lymphocyte regeneration after T lymphocyte-depleted bone marrow transplantation from mismatched family members or matched unrelated donors.
    Cela ME; Holladay MS; Rooney CM; Richardson S; Alexander B; Krance RA; Brenner MK; Heslop HE
    Bone Marrow Transplant; 1996 Feb; 17(2):243-7. PubMed ID: 8640174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of clinical outcomes between unrelated donor peripheral blood stem cell transplantation and bone marrow transplantation for leukemia].
    Fan ZP; Yang K; Liu QF; Sun J; Xu D; Zhang Y; Wei YQ; Ye CX; Jiang QL; Meng FY
    Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):525-8. PubMed ID: 17172125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
    Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
    Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia.
    Passweg JR; Pérez WS; Eapen M; Camitta BM; Gluckman E; Hinterberger W; Hows JM; Marsh JC; Pasquini R; Schrezenmeier H; Socié G; Zhang MJ; Bredeson C
    Bone Marrow Transplant; 2006 Apr; 37(7):641-9. PubMed ID: 16489361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prophylaxis with FK-506 for graft-versus-host disease after transplantation of bone marrow from unrelated donors].
    Hamazaki T; Yagi K; Inoue M; Sakata N; Okamura T; Yasui M; Sasabe M; Kishimoto T; Inoue A; Kawa K
    Rinsho Ketsueki; 2000 May; 41(5):430-6. PubMed ID: 10879106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early identification of patients at risk of death due to infections, hemorrhage, or graft failure after allogeneic bone marrow transplantation on the basis of the leukocyte counts.
    Mehta J; Powles R; Singhal S; Horton C; Middleton G; Eisen T; Meller S; Pinkerton CR; Treleaven J
    Bone Marrow Transplant; 1997 Feb; 19(4):349-55. PubMed ID: 9051245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation.
    Winston DJ; Antin JH; Wolff SN; Bierer BE; Small T; Miller KB; Linker C; Kaizer H; Lazarus HM; Petersen FB; Cowan MJ; Ho WG; Wingard JR; Schiller GJ; Territo MC; Jiao J; Petrarca MA; Tonetta SA
    Bone Marrow Transplant; 2001 Jul; 28(2):187-96. PubMed ID: 11509937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unrelated donor bone marrow transplantation as treatment for chronic myeloid leukemia: the Spanish experience. The Chronic Myeloid Leukemia Subcommittee of the GETH. Grupo Español de Trasplante Hemopoyético.
    Carreras E; Tomás JF; Sanz G; Iriondo A; Boqué C; López J; Cabrera R; Sureda A; de Soria VG; Sierra J; Sanz MA; Torres A
    Haematologica; 2000 May; 85(5):530-8. PubMed ID: 10800172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.